Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q3 2024 Earnings

8AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-10.5

-6.82

-3.14

0.54

Details

Expected EPS

-0.862857

Actual EPS

0.54

Surprise EPS

1.4

Surprise Percent

+162.58%

Description

Cartesian Therapeutics (RNAC) has reported earnings of 0.54 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.